Cargando…

Insulin-like growth factor-1 signaling in renal cell carcinoma

Renal cell carcinoma (RCC) incidence is highest in highly developed countries and it is the seventh most common neoplasm diagnosed. RCC management include nephrectomy and targeted therapies. Type 1 insulin-like growth factor (IGF-1) pathway plays an important role in cell proliferation and apoptosis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tracz, Adam F., Szczylik, Cezary, Porta, Camillo, Czarnecka, Anna M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Debate
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942928/ https://www.ncbi.nlm.nih.gov/pubmed/27405474 http://dx.doi.org/10.1186/s12885-016-2437-4

Ejemplares similares

Insulin and insulin-like growth factors act as renal cell cancer intratumoral regulators
por: Solarek, Wojciech, et al.
Publicado: (2019)

Renin angiotensin system deregulation as renal cancer risk factor
por: Sobczuk, Paweł, et al.
Publicado: (2017)

Pazopanib in Patients with Clear-Cell Renal Cell Carcinoma: Seeking the Right Patient
por: Porta, Camillo, et al.
Publicado: (2017)

Culture in embryonic kidney serum and xeno-free media as renal cell carcinoma and renal cell carcinoma cancer stem cells research model
por: Krawczyk, Krzysztof M., et al.
Publicado: (2018)

Metastatic renal cell carcinoma cells growing in 3D on poly-D-lysine or laminin present a stem-like phenotype and drug resistance
por: Brodaczewska, Klaudia K., et al.
Publicado: (2019)

Choosing the right cell line for renal cell cancer research
por: Brodaczewska, Klaudia K., et al.
Publicado: (2016)

Renal cell carcinoma with intramyocardial metastases
por: Czarnecka, Anna M, et al.
Publicado: (2014)

Development of extracellular matrix supported 3D culture of renal cancer cells and renal cancer stem cells
por: Maliszewska-Olejniczak, Kamila, et al.
Publicado: (2018)

Genomic Analysis as the First Step toward Personalized Treatment in Renal Cell Carcinoma
por: Bielecka, Zofia Felicja, et al.
Publicado: (2014)

Colony, hanging drop, and methylcellulose three dimensional hypoxic growth optimization of renal cell carcinoma cell lines
por: Matak, Damian, et al.
Publicado: (2017)

Mechanisms of Acquired Resistance to Tyrosine Kinase Inhibitors in  Clear - Cell Renal Cell Carcinoma (ccRCC)
por: Bielecka, Zofia F., et al.
Publicado: (2013)

The role of the cell–cell interactions in cancer progression
por: Kamińska, Katarzyna, et al.
Publicado: (2015)

Mammalian Target of Rapamycin Inhibitors Resistance Mechanisms in Clear Cell Renal Cell Carcinoma
por: Kornakiewicz, Anna, et al.
Publicado: (2013)

Biomarkers defining probability of receiving second-line targeted therapy in metastatic renal cell carcinoma
por: Chrom, Pawel, et al.
Publicado: (2018)

Metastatic Tumor Burden and Loci as Predictors of First Line Sunitinib Treatment Efficacy in Patients with Renal Cell Carcinoma
por: Czarnecka, Anna M., et al.
Publicado: (2019)

Current approaches in identification and isolation of human renal cell carcinoma cancer stem cells
por: Khan, Mohammed I., et al.
Publicado: (2015)

Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer Cells
por: Khan, Mohammed I., et al.
Publicado: (2016)

Thyroid Hormones as Renal Cell Cancer Regulators
por: Szymański, Łukasz, et al.
Publicado: (2016)

Metastasis-Initiating Cells in Renal Cancer
por: Khan, Mohammed I., et al.
Publicado: (2013)

The Role of Hypoxia and Cancer Stem Cells in Renal Cell Carcinoma Pathogenesis
por: Myszczyszyn, Adam, et al.
Publicado: (2015)

Seeking new prognostic and predictive factors in patients with metastatic renal cell carcinoma – apoptosis-regulating factors
por: Młot, Beata, et al.
Publicado: (2012)

Seeking new prognostic and predictive factors in patients with metastatic renal cell carcinoma – hypoxia-induced factors
por: Młot, Beata, et al.
Publicado: (2012)

Functional significance of CD105-positive cells in papillary renal cell carcinoma
por: Matak, Damian, et al.
Publicado: (2017)

Evaluation of surrogate measures of insulin sensitivity - correlation with gold standard is not enough
por: Rudvik, Anna, et al.
Publicado: (2018)

Involvement of the CB(2) cannabinoid receptor in cell growth inhibition and G0/G1 cell cycle arrest via the cannabinoid agonist WIN 55,212–2 in renal cell carcinoma
por: Khan, Mohammed I., et al.
Publicado: (2018)

Effects of cell-cell crosstalk on gene expression patterns in a cell model of renal cell carcinoma lung metastasis
por: Kaminska, Katarzyna, et al.
Publicado: (2017)

Is a hypothetical melanoma-like neuromelanin the underlying factor essential for the aetiopathogenesis and clinical manifestations of multiple sclerosis?
por: Krone, Bernd, et al.
Publicado: (2013)

Biology of renal tumour cancer stem cells applied in medicine
por: Matak, Damian, et al.
Publicado: (2015)

Immune consequences of anti-angiogenic therapyin renal cell carcinoma
por: Brodaczewska, Klaudia K., et al.
Publicado: (2018)

No association of the insulin gene VNTR polymorphism with polycystic ovary syndrome in a Han Chinese population
por: Xu, Yuping, et al.
Publicado: (2009)

Vitamin D receptor gene polymorphisms in breast and renal cancer: Current state and future approaches
por: KHAN, MOHAMMED I., et al.
Publicado: (2013)

Fatty acid-induced mitochondrial uncoupling in adipocytes as a key protective factor against insulin resistance and beta cell dysfunction: a new concept in the pathogenesis of obesity-associated type 2 diabetes mellitus
por: Maassen, J. A., et al.
Publicado: (2007)

Medical therapy is best for atherosclerotic renal artery stenosis: Arguments for
por: Annigeri, R. A.
Publicado: (2012)

Axitinib in sequential therapy in metastatic renal cell carcinoma
por: Kuchar, Agata, et al.
Publicado: (2016)

Ethical issues relating to renal transplantation from prediabetic living donor
por: Ferreira-Hermosillo, Aldo, et al.
Publicado: (2014)

Partial Nephrectomy for Metastatic Renal Cell Carcinoma: Pro
por: Campbell, Steven C., et al.
Publicado: (2022)

Pros and cons of a prion-like pathogenesis in Parkinson's disease
por: Hilker, Ruediger, et al.
Publicado: (2011)

Current clinical management of constitutional delay of growth and puberty
por: Gaudino, Rossella, et al.
Publicado: (2022)

Why statistical inference from clinical trials is likely to generate false and irreproducible results
por: Hanin, Leonid
Publicado: (2017)

Catalyzing marketing innovation and competitive advantage in the healthcare industry: the value of thinking like an outsider
por: Elrod, James K., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l0a2e3pl1urvikgha7h7gluid6